1. University of Texas System (28 from 5,444 patents)

2. Moleculin Biotech, Inc. (4 from 4 patents)

3. Other (3 from 832,680 patents)

4. Houston Pharmaceuticals, Inc. (2 from 3 patents)

5. University of Mississippi (1 from 155 patents)

6. Moleculin, LLC (1 from 1 patent)

7. Priebe, Waldemar (0 patent)

8. Przewloka, Teresa (0 patent)

9. Fokt, Izabela (0 patent)

10. Skibicki, Piotr (0 patent)

11. Krawczyk, Marta (0 patent)

12. Perez-soler, Roman (0 patent)

13. Grynkiewicz, Grzegorz (0 patent)

1. 12257262 - Method of reconstituting liposomal annamycin

2. 12257261 - Preparation of preliposomal Annamycin lyophilizate

3. 11980634 - Method of reconstituting liposomal annamycin

4. 11951118 - Preparation of preliposomal annamycin lyophilizate

5. 11925654 - Esters of 2-deoxy-monosaccharides with anti proliferative activity

6. 11026960 - Esters of 2-deoxy-monosaccharides with anti proliferative activity

7. 10703721 - Caffeic acid derivatives and uses thereof

8. 10358439 - DNA binding agents with a minor groove binding tail

9. 10201554 - Esters of 2-deoxy-monosacharides with anti proliferative activity

10. 9096499 - Compounds for treatment of cell proliferative diseases

11. 9000179 - Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)

12. 8927506 - Acetates of 2-deoxy monosaccharides with anticancer activity

13. 8779151 - Orally bioavailable caffeic acid related anticancer drugs

14. 8648102 - Compounds for treatment of cell proliferative diseases

15. 8637675 - Inhibitors of proliferation and activation of signal transducer and activators of transcription (STATS)